These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3488426)

  • 1. [Abnormal proliferation of large granular lymphocytes with natural killer activity and peculiar phenotype (HNK-1+, OKT 3+, 4+, 8+ and IgG EA-)].
    Okabe M; Matsuno K; Sasaki O; Saito N; Nishikawa S; Minagawa T; Sakurada K; Miyazaki T
    Rinsho Ketsueki; 1986 Mar; 27(3):369-75. PubMed ID: 3488426
    [No Abstract]   [Full Text] [Related]  

  • 2. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
    Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB
    J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of NK cell activity and proliferation in cultured lymphocytes of leukemic patients by monoclonal antibodies CD3 and interleukin-2.
    Soucek J; Hilgert I; Budová I; Lindnerová G
    Neoplasma; 1994; 41(2):75-81. PubMed ID: 8208318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human large granular lymphocyte clone with natural killer-like activity and T cell-like surface markers.
    Sheehy MJ; Quintieri FB; Leung DY; Geha RS; Dubey DP; Limmer CE; Yunis EJ
    J Immunol; 1983 Feb; 130(2):524-6. PubMed ID: 6600239
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
    Tilden AB; Abo T; Balch CM
    J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.
    Pandolfi F; Semenzato G; de Rossi G; Quinti I; Guglielmi C; Pezzutto A; Lopez M; Tonietti G; Fontana L; Abo T; Aiuti F
    Clin Exp Immunol; 1983 Jun; 52(3):641-7. PubMed ID: 6603302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of granular lymphocyte proliferation with T-cell phenotype.
    Toki H; Okabe K; Kimura Y
    Jpn J Clin Oncol; 1985 Mar; 15(1):151-9. PubMed ID: 3872376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia.
    Gupta S; Fernandes G
    J Clin Lab Immunol; 1983 Nov; 12(3):155-7. PubMed ID: 6607357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
    Rumpold H; Kraft D; Gastl G; Huber C
    Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells.
    Allavena P; Klein R; Ortaldo JR
    Nat Immun Cell Growth Regul; 1985; 4(1):7-20. PubMed ID: 3875792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
    Abo T; Miller CA; Balch CM; Cooper MD
    J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characteristics of human natural killer cells.
    Perussia B; London L; Trinchieri G
    Biomed Pharmacother; 1985; 39(1):13-8. PubMed ID: 3875369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent asymptomatic lymphocytosis with large granular lymphocyte predominance (NK phenotype).
    Airò R; Baldini L; Ferrari CM; Neri A; Airò P
    Haematologica; 1985; 70(3):245-9. PubMed ID: 3932155
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinction between T gamma lymphocytosis and other T-cell proliferations with monoclonal antibodies against T-cell and natural killer (NK) cell subsets.
    Van de Griend RJ; Ligthart GJ; Den Ottolander GJ; Bolhuis RL
    Neth J Med; 1985; 28(3):96-101. PubMed ID: 3872421
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
    Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
    J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signaling.
    Yamasaki S; Maeda M; Ohshima K; Kikuchi M; Otsuka T; Harada M
    Leuk Res; 2004 Oct; 28(10):1023-31. PubMed ID: 15289013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.